Literature DB >> 17210829

Excessive sympathetic activation in heart failure with obesity and metabolic syndrome: characteristics and mechanisms.

Guido Grassi1, Gino Seravalle, Fosca Quarti-Trevano, Francesco Scopelliti, Raffaella Dell'Oro, Gianbattista Bolla, Giuseppe Mancia.   

Abstract

Congestive heart failure is characterized by sympathetic activation, which has also been described in the metabolic syndrome. No information exists, however, as to whether the sympathostimulating effects of these 2 conditions summate when heart failure is complicated by the metabolic syndrome, leading to an exceedingly high adrenergic drive. This is clinically relevant, because in heart failure sympathetic activation is closely related to mortality. We studied 48 control subjects (age: 58.4+/-1.6 years, mean+/-SEM) and 89 age-matched heart failure patients (New York Heart Association class II), of whom 47 were without and 42 were with metabolic syndrome. Measurements included blood pressure (Finapres), heart rate (ECG), and sympathetic nerve traffic (microneurography) at rest and during baroreceptor manipulation. Waist circumference, blood pressure, and metabolic variables were greater in heart failure with metabolic syndrome than in heart failure without metabolic syndrome and in control subjects. Left ventricular ejection fraction and end-diastolic diameter were similarly altered in the 2 heart failure groups. Compared with control subjects, sympathetic nerve activity was greater in heart failure patients without metabolic syndrome (64.7+/-3.2 versus 45.8+/-2.9 bursts/100 heartbeats; P<0.01), a further pronounced increase being detected in those with metabolic syndrome (80.9+/-3.2 bursts/100 heartbeats; P<0.01). In the multivariate analysis, waist circumference and body mass index were the variables most closely related to sympathetic activation. Compared with control subjects, baroreflex responses were significantly attenuated in the 2 heart failure groups, the impairment being more marked in the group with than without metabolic syndrome. Thus, obesity and metabolic syndrome potentiate the sympathetic activation characterizing heart failure. This potentiation is likely to mainly depend on metabolic and baroreflex mechanisms.

Entities:  

Mesh:

Year:  2007        PMID: 17210829     DOI: 10.1161/01.HYP.0000255983.32896.b9

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  34 in total

1.  Abnormal sympathetic reactivity to the cold pressor test in overweight humans.

Authors:  Jeanie Park; Holly R Middlekauff; Vito M Campese
Journal:  Am J Hypertens       Date:  2012-08-16       Impact factor: 2.689

2.  Adiposity-independent sympathetic activity in black men.

Authors:  Aamer Abbas; Lidia S Szczepaniak; Meryem Tuncel; Jonathan M McGavock; Beverley Huet; Paul J Fadel; Zhongyun Wang; Debbie Arbique; Ronald Victor; Wanpen Vongpatanasin
Journal:  J Appl Physiol (1985)       Date:  2010-03-18

3.  Target organ complications and prognostic significance of alerting reaction: analysis from the Dallas Heart Study.

Authors:  Alejandro Velasco; Colby Ayers; Sandeep R Das; James A de Lemos; Amit Khera; Ronald G Victor; Norman M Kaplan; Wanpen Vongpatanasin
Journal:  J Hypertens       Date:  2016-02       Impact factor: 4.844

Review 4.  Residual vascular dysfunction in women with a history of preeclampsia.

Authors:  Anna E Stanhewicz
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2018-08-22       Impact factor: 3.619

Review 5.  Diagnostic imaging in the management of patients with metabolic syndrome.

Authors:  Seo Rin Kim; Lilach O Lerman
Journal:  Transl Res       Date:  2017-11-22       Impact factor: 7.012

Review 6.  Cardiovascular consequences of metabolic syndrome.

Authors:  Johnathan D Tune; Adam G Goodwill; Daniel J Sassoon; Kieren J Mather
Journal:  Transl Res       Date:  2017-01-09       Impact factor: 7.012

Review 7.  ESC Working Group on Coronary Pathophysiology and Microcirculation position paper on 'coronary microvascular dysfunction in cardiovascular disease'.

Authors:  Teresa Padro; Olivia Manfrini; Raffaele Bugiardini; John Canty; Edina Cenko; Giuseppe De Luca; Dirk J Duncker; Etto C Eringa; Akos Koller; Dimitris Tousoulis; Danijela Trifunovic; Marija Vavlukis; Cor de Wit; Lina Badimon
Journal:  Cardiovasc Res       Date:  2020-03-01       Impact factor: 10.787

8.  Overview of the i-SEARCH Global Study : Cardiovascular Risk Factors and Microalbuminuria in Hypertensive Individuals.

Authors:  Michael Böhm; Martin Thoenes; Nicolas Danchin; Jan C Reil; Massimo Volpe
Journal:  High Blood Press Cardiovasc Prev       Date:  2013-01-22

Review 9.  Central sympathetic overactivity: maladies and mechanisms.

Authors:  James P Fisher; Colin N Young; Paul J Fadel
Journal:  Auton Neurosci       Date:  2009-03-06       Impact factor: 3.145

10.  How 40 kilograms of fluid retention can be overlooked: two case reports.

Authors:  Hon Shing Ong; Candy Wing-Chiu Sze; Tat Woon Koh; Simon Ward Coppack
Journal:  Cases J       Date:  2009-01-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.